Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104585 · ClinicalTrials.gov registry record
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)
A clinical trial of Parkinson's Disease, sponsored by Columbia University.
- Completed
- Registry status
- 750
- Enrollment target
- 1
- Study location
NCT00104585 is a study of Parkinson's Disease that has completed, run by Columbia University. The registered enrollment target is 750 participants, above the 638-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00104585, a study of Parkinson's Disease, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate genetic and environmental risk factors that increase susceptibility to the development of early-onset Parkinson's disease (developed at or before age 50).
Conditions Studied
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2004-07 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00104585
The ClinicalTrials.gov registry entry for NCT00104585 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 638-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (18% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00104585 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00104585 about?
NCT00104585 is a clinical study titled "Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)". The purpose of this study is to investigate genetic and environmental risk factors that increase susceptibility to the development of early-onset Parkinson's disease (developed at or before age 50).
What is the current status of trial NCT00104585?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2004-07. Estimated completion is 2014-11.
What conditions does trial NCT00104585 study?
This clinical trial studies the following conditions: Parkinson's Disease.
Who is sponsoring clinical trial NCT00104585?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00104585 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.